GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast Track designation ...
Mangaciclanol’s Phase I trial showed it was well tolerated, with no serious adverse events or clinically significant findings ...
Ultrasounds are a critical part of modern health care, helping to image soft tissue and organs, measure blood flow, and ...
Zacks Investment Research on MSN
GEHC moves manganese-based MRI contrast agent into phase 2/3 trial
GE HealthCare Technologies Inc. GEHC recently announced that the first patient has been dosed in its Phase 2/3 LUMINA ...
Over 1 billion people worldwide are living with one or more mental health disorders that affect their mood, thinking ...
For people at high risk of breast cancer, timely and accurate screening can be lifesaving, helping doctors to find cancer ...
Discover how medical 3D printing creates patient-specific devices and custom prosthetics. Read our guide to clinical ...
The mobile MRI service for patients in the Albany, Caverna, and Russellville communities.
A new MRI system at Deaconess Illinois Medical Center is expected to change how quickly patients in Southern Illinois get ...
Med Center Health is beginning a new mobile MRI service for patients in the Kentucky communities of Albany, Caverna, and ...
A new piece of advanced medical technology now up and running in Marion is being called a major step forward for healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results